SCM
RCEL icon

Sterling Capital Management’s Avita Medical RCEL Stock Holding History

Sterling Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-79
Closed -$292 – 3388
2026
Q1 		$292 Hold
79
– – ﹤0.01% 3187
2025
Q4 		$273 Buy
79
+49
+163% +$196 ﹤0.01% 3217
2025
Q3 		$153 Sell
30
-31
-51% -$162 ﹤0.01% 3225
2025
Q2 		$323 Buy
61
+35
+135% +$255 ﹤0.01% 3200
2025
Q1 		$212 Hold
26
– – ﹤0.01% 3077
2024
Q4 		$333 Hold
26
– – ﹤0.01% 3074
2024
Q3 		$279 Buy
+26
New +$244 ﹤0.01% 3049

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sterling Capital Management's RCEL Position: Q2 2026 in Review

Sterling Capital Management sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 79 shares — an estimated $292 sold.

Sterling Capital Management first reported a position in RCEL in Q3 2024 and held it in 7 quarters. The position peaked at $333 in Q4 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Sterling Capital Management reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • Sterling Capital Management sold 79 Avita Medical shares in Q2 2026, an estimated $292.
  • Sterling Capital Management first reported a position in Avita Medical in Q3 2024 and held it in 7 quarters.
  • Sterling Capital Management's Avita Medical position peaked at $333 in Q4 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.